By Melanie Barnard1. Retatrutide (LY3437943)Category: Investigational Triple-Hormone Receptor AgonistDeveloper: Eli Lilly & Co.Primary Focus: Weight loss, metabolic health, type 2 diabetesOverviewRetatrutide is the newest and most advanced peptide in the GLP-1 class, designed as a triple agonist, meaning it activates three key hormone receptors: GLP-1, GIP, and glucagon. These receptors play major roles in controlling …
By Melanie Barnard
1. Retatrutide (LY3437943)
Category: Investigational Triple-Hormone Receptor Agonist
Developer: Eli Lilly & Co.
Primary Focus: Weight loss, metabolic health, type 2 diabetes
Overview
Retatrutide is the newest and most advanced peptide in the GLP-1 class, designed as a triple agonist, meaning it activates three key hormone receptors: GLP-1, GIP, and glucagon. These receptors play major roles in controlling appetite, blood sugar, and energy expenditure.
Retatrutide is being called the “next-generation” of semaglutide (Ozempic) and tirzepatide (Mounjaro) — offering even greater weight-loss potential.
Mechanism of Action
Retatrutide acts on:
- GLP-1 Receptors → Reduce appetite, slow stomach emptying, regulate insulin release
- GIP Receptors → Enhance insulin sensitivity, improve fat metabolism
- Glucagon Receptors → Increase resting energy expenditure and fat oxidation
Together, these create a synergistic effect, helping the body burn fat while controlling hunger and stabilizing glucose.
Clinical / Research Findings
In a Phase 2 clinical trial published in The New England Journal of Medicine, participants lost up to 24% of total body weight in 48 weeks — one of the most significant results ever reported for a medication of this type.
Improvements were also seen in blood sugar control, liver fat reduction, and cholesterol levels.
Side effects were similar to other GLP-1-based drugs: nausea, vomiting, diarrhea, but generally well-tolerated after dose adjustment.
Potential Benefits
- Significant weight loss (greater than current GLP-1s)
- Improved insulin sensitivity and metabolic health
- May reduce fatty liver and cardiometabolic risk factors
- Could help with appetite control and emotional eating patterns
Possible Side Effects & Risks
- GI upset (nausea, bloating, constipation)
- Fatigue, dehydration
- Risk of low blood sugar if combined with insulin/sulfonylureas
- Rare: pancreatitis, gallbladder issues, thyroid concerns (based on rodent data)
Status & Legal Considerations
- Not yet FDA approved (still in trials)
- Available only through clinical trials or research purposes only
2. BPC-157 (Body Protection Compound-157
Category: Regenerative Peptide
Origin: Derived from a protective protein found in the human stomach
Primary Focus: Tissue repair, inflammation reduction, recovery
Overview
BPC-157 is a naturally occurring healing peptide found in gastric juices. It has been shown in numerous animal studies to speed up tissue regeneration, repair muscle and tendon damage, and reduce inflammation.
Often referred to as the “healing peptide,” it’s popular among biohackers, athletes, and regenerative medicine clinics — though it remains unapproved for medical use in humans.
Mechanism of Action
BPC-157 promotes healing through several pathways:
- Increases angiogenesis (formation of new blood vessels)
- Upregulates growth factors like VEGF and FGF for faster tissue repair
- Protects the gut lining and reduces inflammation in the digestive tract
- Enhances fibroblast migration and collagen production at injury sites
This helps accelerate recovery from soft tissue damage, tendinitis, and surgical wounds.
Clinical / Research Findings
Rodent studies show accelerated healing of tendons, ligaments, bone, and intestinal tissue.
Neuroprotective effects: may help repair nerve injury and reduce brain inflammation.
Gut healing: protective effects in colitis, leaky gut, and stomach ulcer models.
No major human trials have yet been completed — evidence remains preclinical.
Potential Benefits
- Faster wound and muscle recovery
- Reduced inflammation and joint pain
- Improved digestive health and gut repair
- Possible neuroprotective and mood-balancing effects
Possible Side Effects & Risks
- Limited data — long-term safety unknown
- Possible overstimulation of angiogenesis
- Injection site redness or swelling
- Unknown dosing standards due to lack of regulation
Status & Legal Considerations
- Not approved by the FDA for human use
- WADA-banned (World Anti-Doping Agency) for athletes
- Commonly sold as a research chemical
3. TB-500 (Thymosin Beta-4 Fragment)
Category: Regenerative / Repair Peptide
Origin: Synthetic fragment of thymosin beta-4, a natural protein found in human and animal tissues
Primary Focus: Cell regeneration, injury recovery, inflammation reduction
Overview
TB-500 is a synthetic version of a portion of Thymosin Beta-4, a peptide naturally present in almost all human cells. It helps regulate actin — a protein essential for cell structure and movement — making it key in wound healing and tissue remodeling.
It’s widely used in regenerative and sports medicine for faster recovery after injuries, surgeries, or intense physical strain.
Mechanism of Action
TB-500 works by:
- Upregulating actin and cell migration to accelerate tissue repair
- Stimulating angiogenesis (formation of new blood vessels)
- Reducing inflammatory cytokines
- Promoting stem cell recruitment to damaged areas
Together, these actions enhance healing speed and tissue flexibility.
Clinical / Research Findings
Animal models: improved healing in tendon and muscle injuries, heart tissue repair post-heart attack.
May reduce scar tissue formation and improve flexibility of healed tissue.
Human data: limited to anecdotal or small case reports.
Combined with BPC-157, results may be synergistic — enhancing overall healing response.
Potential Benefits
- Accelerated wound healing and tissue regeneration
- Reduced inflammation and fibrosis
- Improved recovery after aesthetic or surgical procedures
- Potential cardioprotective effects
Possible Side Effects & Risks
- Minimal injection site irritation
- Possible fatigue or headache
- Unknown long-term safety
As with all unregulated peptides, product purity and contamination risk are concerns
Status & Legal Considerations
- Not FDA approved
- For research purposes only in the U.S.
- Use in human clients should be disclosed as off-label or investigational
- Not permitted for competitive athletes (WADA ban)
Melanie Barnard
Book a Consultation





